Regulation - Merck & Co, Gastro-intestinals

Filter

Popular Filters

Merck & Co gets positive CHMP opinion for Remicade in new indication

22-01-2012

US drug giant Merck & Co (NYSE: MRK) says that announced that the European Medicines Agency’s Committee…

EuropeGastro-intestinalsMerck & CoPharmaceuticalRegulationRemicade

Company Spotlight

ImmunoGen

ImmunoGen

Back to top